Total planned funding: $52,187,771
Clear active filters
U.S. Department of State
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $7,984,144 |
| Ethiopia | $7,731,159 |
| South Africa | $6,731,014 |
| Mozambique | $5,955,317 |
| Botswana | $5,523,864 |
| Guyana | $4,214,017 |
| Uganda | $3,101,579 |
| Namibia | $2,695,090 |
| Kenya | $2,307,715 |
| Zambia | $2,153,344 |
| Caribbean Region | $1,000,000 |
| Malawi | $515,950 |
| Nigeria | $363,000 |
| Lesotho | $332,285 |
| Zimbabwe | $302,000 |
| Eswatini | $296,365 |
| Rwanda | $262,136 |
| Ghana | $215,000 |
| Côte d'Ivoire | $190,008 |
| Cameroon | $150,000 |
| Central America Region | $98,784 |
| Vietnam | $65,000 |
| Democratic Republic of the Congo | $0 |
| Haiti | $0 |
Organizational Types
| Other USG Agency | $42,038,919 |
| Own Agency | $10,108,852 |
| Implementing Agency | $40,000 |
Program Areas
| Treatment | $13,563,107 |
| Governance and Systems | $12,405,100 |
| Management and Operations | $10,504,341 |
| Care | $8,151,282 |
| Prevention | $6,517,279 |
| Testing | $1,046,662 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $13,390,257 |
| HVMS: Management and Operations | $10,504,341 |
| HLAB: Laboratory Infrastructure | $8,286,677 |
| HKID: Care: Orphans and Vulnerable Children | $5,157,067 |
| HMBL: Biomedical Prevention: Blood Safety | $4,070,000 |
| OHSS: Health Systems Strengthening | $3,659,343 |
| HVTB: Care: TB/HIV | $1,642,146 |
| HBHC: Care: Adult Care and Support | $1,258,652 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,226,303 |
| HVCT: Testing: HIV Testing and Counseling | $1,046,662 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $993,838 |
| HVSI: Strategic Information | $459,080 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $134,518 |
| PDCS: Care: Pediatric Care and Support | $93,417 |
| PDTX: Treatment: Pediatric Treatment | $92,146 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $88,806 |
| HTXD: Treatment: ARV Drugs | $80,704 |
| HMIN: Biomedical Prevention: Injection Safety | $3,814 |